• where experts go to learn about FDA
  • Miscellaneous

    • ACI’s 13th Annual Summit for Women Leaders in Life Sciences LawJune 30th, 2026

      The American Conference Institute’s (“ACI”) 13th Annual Summit for Women Leaders in Life Sciences Law returns July 29-30, 2026, at the Seaport Hotel Boston in Boston, Massachusetts. ACI’s Summit for Women Leaders in Life Sciences Law is dedicated to providing the invaluable opportunities for networking and …

    • HPM Announces Firm and Attorney Selection for 2026 Chambers USA GuideJune 5th, 2026

      Hyman, Phelps & McNamara, P.C. is proud to announce that the Firm and five of the Firm’s attorneys have been selected for the 2026 Chambers USA Guide. Recognitions include: Firm Rankings Healthcare: Pharmaceutical/Medical Products Regulatory (District of Columbia) – Band 3 Food & Beverages: Regulatory & Litigation (USA – …

    • Job Opportunity: HPM Seeks Junior to Mid-Level Attorney with Healthcare Law ExperienceMarch 17th, 2026

      Hyman, Phelps & McNamara, P.C., one of the nation’s largest boutique food and drug regulatory law firms, seeks to add a junior to mid-level associate with three to five years of experience to its healthcare compliance team. This associate should have experience providing advice to life …

    • Hyman, Phelps & McNamara, P.C. Recognized in the 2026 Best Law Firms® RankingsDecember 22nd, 2025

      We are proud to announce that Hyman, Phelps & McNamara, P.C. (HPM) has been named to the 2026 Best Law Firms® list, receiving top-tier recognition for our work in FDA Law. The firm earned: National Tier 1 – FDA Law Regional Tier 1, Washington, D.C. – FDA …

    • HPM Announces the Promotion of Steven Gonzalez to CounselNovember 24th, 2025

      Hyman, Phelps & McNamara, P.C. (HPM) is pleased to announce that Steven Gonzalez has been promoted to Counsel. Steven joined the firm in 2022 and has quickly become a trusted advisor to clients navigating complex FDA regulatory and compliance matters. His practice focuses on advising pharmaceutical …

    • Tom Scarlett: 1943 – 2025August 27th, 2025

      With great sadness, we announce that our colleague and friend Tom Scarlett passed away on August 20, 2025, at the age of 82.  Tom was a great lawyer, a recognized leader of the food and drug bar, and an unexcelled teacher and inspiration to all …

    • Hyman, Phelps & McNamara, P.C. Congratulates 16 Attorneys Named to The Best Lawyers in America® 2026 EditionAugust 24th, 2025

      Hyman, Phelps & McNamara, P.C. (“HP&M”) is proud to announce that 16 of our attorneys have been recognized in the 2026 edition of The Best Lawyers in America®. This recognition reflects the depth of our team’s experience and our ongoing commitment to excellence in FDA law, …

    • HP&M Welcomes Peter Dickos to the FirmJuly 24th, 2025

      Hyman, Phelps & McNamara, P.C. (“HP&M”) is pleased to announce that Peter “Pete” Dickos has joined the firm as Counsel. Pete brings nearly a decade of high-level government experience to HP&M’s Enforcement and Litigation practice, with a particular focus on complex regulatory and litigation challenges involving …

    • HP&M Seeks Experienced Regulatory ExpertJuly 2nd, 2025

      Hyman, Phelps & McNamara, P.C. (HP&M) seeks to add an experienced regulatory expert to our strong and busy team of non-attorney regulatory experts.  Our team assists clients with a wide variety of quality and manufacturing regulatory topics for drugs and biologics.  Types of matters include: Developing …

    • Hyman, Phelps & McNamara Enters its 45th Year Continuing to Expand its Capabilities to Meet Client NeedsApril 6th, 2025

      Hyman, Phelps & McNamara (HPM) marks its 45th Anniversary year by welcoming three accomplished professionals who reinforce the depth and breadth of the firm’s FDA and DEA practices. Naomi Lowy joins HPM as a Principal Drug Regulatory Expert after 18 years at the FDA’s Center for Drug …

    • FOIA Requires Transparency of Instructions to FDA Staff, Even When Those Instructions Are to Pause Communications with the PublicJanuary 31st, 2025

      During the Regulatory Freeze Pending Review and  the HHS Immediate Pause on Issuing Documents and Public Communications, our thoughts turned to the principles underlying the Freedom of Information Act (FOIA).  As the DOJ FOIA Guide explains in its introduction: The United States Supreme Court has explained …

    • What We’re Watching for in the Senate Confirmation Hearings to Consider Robert F. Kennedy, Jr. to be Secretary of HHSJanuary 29th, 2025

      The confirmation hearings for Robert F. Kennedy, Jr. to lead the Department of Health and Human Services kick off at 10 am on January 29 and promise to have a packed agenda. With oversight over FDA, the Centers for Medicare & Medicaid Services, the National …

    • HPM Grows Its Ranks of Directors, Counsel, and Associates as it begins its 45th Anniversary YearJanuary 17th, 2025

      Hyman, Phelps & McNamara PC, (HPM), which will mark its 45th Anniversary on March 17, 2025, is pleased to announce that it is increasing its directors, counsel, and associates as it starts the year. Kalie E. Richardson has been promoted to Director. Mark Tobolowsky has been promoted to …

    • Sixteen HP&M Attorneys Recognized by Best Lawyers® in 2025 in AmericaSeptember 5th, 2024

      Hyman, Phelps & McNamara, P.C. (“HP&M”) is proud to announce that 16 of the Firm’s attorneys have been selected to the 2025 edition of The Best Lawyers in America®.  Founding Director Paul M. Hyman has been rightfully chosen as a 2025 “Lawyer of the Year.”  …

    • The Summit for Women Leaders in Life Sciences LawJuly 31st, 2024

      The American Conference Institute (“ACI”) held its 11th Annual Summit for Women Leaders in Life Sciences Law at the Seaport Hotel in Boston, Massachusetts on July 25th & 26th of last week.  Several leading ladies in law at HPM attended the conference and, based on their …